DNA Unlimited

The vendor opportunity at DNA Unlimited

DNA Unlimited operates 3,786 franchised home-services locations across the United States, with the heaviest concentration in Florida (36 units), California (34), Ohio (25), Georgia (19), and Tennessee (19). Every one of those locations is run by a single-unit franchisee—the FDD maps 254 operators across roughly 254 units, and no multi-unit operators are recorded. For a software vendor, that means the addressable market is large but atomized: 3,786 independent buying decisions, not a handful of multi-unit owners writing a single check.

The brand’s 2025 FDD does not disclose an average unit volume, so you cannot benchmark a typical operator’s willingness to pay against revenue. Royalties run at 5.0% of gross sales, and the initial franchise term is 12 years. Year-over-year unit growth is not reported, so the net-new-location pipeline is opaque.

Who controls software purchasing

The FDD’s Item 1 lists exactly one individual at HQ: David Kramer, identified as the agent for service of process. No CEO, CIO, CTO, VP of Operations, or procurement manager is named. That does not mean those roles do not exist—it means the franchisor has not surfaced them in the disclosure document. For a vendor building an org chart, the starting point is thin. You are likely looking at a flat management structure where the owner-operator relationship is direct and lightly intermediated.

Because every unit is franchised and no multi-unit operators appear, the real software buyer is the individual franchisee. There is no corporate-owned fleet to pilot a tool and force adoption downstream. A top-down sale is improbable; a ground-up, operator-by-operator motion is the only path visible in the data.

Mandated and current tech stack

The 2025 FDD contains no Item 11 technology mandates. No POS system, no CRM, no scheduling platform, no accounting package is required or recommended by the franchisor. This is a blank-slate environment: franchisees are free to choose whatever tools they want, and the franchisor does not appear to aggregate or resell any software.

For a vendor, that is both opportunity and friction. You do not have to displace an incumbent mandated by HQ, but you also have no single integration point or endorsement to leverage. Every sale starts cold.

Procurement, renewals, and timing

Item 8—the section that would describe designated suppliers, approved-supplier programs, or purchasing cooperatives—yields no extract in the 2025 FDD. That silence suggests an open procurement environment, but it is not a guarantee. Vendors should verify directly whether the franchisor maintains an informal preferred-vendor list that does not rise to the level of an FDD disclosure.

Renewal timing offers a recurring window. Under Item 17, a franchisee in good standing may renew by notifying the franchisor between 180 and 60 days before the 12-year term expires, then signing a new agreement at least 30 days before expiration. The new agreement may contain materially different terms, and the franchisee must update equipment and supplies. That equipment-update clause is the natural moment when a franchisee evaluates new software. With 3,786 units on staggered 12-year cycles, some subset is always approaching renewal and may be more receptive to a pitch that aligns with a required refresh.

How to read the DNA Unlimited FDD

The embedded viewer below loads the full 2025 FDD. Key sections for a software vendor: Item 1 (the agent for service is your only named HQ contact), Item 8 (procurement—silent here), Item 11 (tech mandates—absent), and Item 17 (renewal conditions and timing). Because the document names no technology vendors, your competitive intelligence will have to come from field conversations, not from the disclosure.

If you sell software into home-services franchises, DNA Unlimited’s 3,786 single-unit operators represent a large, unaffiliated target set with no franchisor-imposed tech stack. FranCloud can help you rank and prioritize those operators by geography, renewal window, and other signals.